|
1
|
Bertuccio P, Chatenoud L, Levi F, Praud D,
Ferlay J, Negri E, Malvezzi M and La Vecchia C: Recent patterns in
gastric cancer: A global overview. Int J Cancer. 125:666–673. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Correa P: Human gastric carcinogenesis: A
multistep and multifactorial process-first American cancer society
award lecture on cancer epidemiology and prevention. Cancer Res.
52:6735–6740. 1992.PubMed/NCBI
|
|
3
|
Tahara E, Yasui W and Yokozaki H: Genetic
alterations in stomach cancer. Nihon Geka Gakkai zasshi.
97:252–256. 1996.(In Japanese). PubMed/NCBI
|
|
4
|
Patel TN, Roy S and Ravi R: Gastric cancer
and related epigenetic alterations. Ecancermedicalscience.
11:7142017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wakefield RI, Smith BO, Nan X, Free A,
Soteriou A, Uhrin D, Bird AP and Barlow PN: The solution structure
of the domain from MeCP2 that binds to methylated DNA. J Mol Biol.
291:1055–1065. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao L, Liu Y, Tong D, Qin Y, Yang J, Xue
M, Du N, Liu L, Guo B, Hou N, et al: MeCP2 promotes gastric cancer
progression through regulating FOXF1/Wnt5a/β-Catenin and
MYOD1/Caspase-3 signaling pathways. EBioMedicine. 16:87–100. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang F, Yuan JH, Wang SB, Yang F, Yuan SX,
Ye C, Yang N, Zhou WP, Li WL, Li W and Sun SH: Oncofetal long
noncoding RNA PVT1 promotes proliferation and stem cell-like
property of hepatocellular carcinoma cells by stabilizing NOP2.
Hepatology. 60:1278–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu ZJ, Li Y, Wu YZ, Wang Y, Nian WQ, Wang
LL, Li LC, Luo HL and Wang DL: Long non-coding RNA CCAT2 promotes
the breast cancer growth and metastasis by regulating TGF-β
signaling pathway. Eur Rev Med Pharmacol Sci. 21:706–714.
2017.PubMed/NCBI
|
|
10
|
Wang D, Wang D, Wang N, Long Z and Ren X:
Long Non-Coding RNA BANCR promotes endometrial cancer cell
proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK
signaling pathway. Cell Physiol Biochem. 40:644–656. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Zhang X, Shi J, Cao P, Wan M,
Zhang Q, Wang Y, Kridel SJ, Liu W, Xu J, et al: Fatty acid synthase
is a primary target of MiR-15a and MiR-16-1 in breast cancer.
Oncotarget. 7:78566–78576. 2016.PubMed/NCBI
|
|
12
|
Leveille N, Melo CA, Rooijers K,
Díaz-Lagares A, Melo SA, Korkmaz G, Lopes R, Akbari Moqadam F, Maia
AR, Wijchers PJ, et al: Genome-wide profiling of p53-regulated
enhancer RNAs uncovers a subset of enhancers controlled by a
lncRNA. Nat Commun. 6:65202015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kumaki Y, Oda M and Okano M: QUMA:
Quantification tool for methylation analysis. Nucleic Acids Res.
36:W170–W175. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tong D, Zhao L, He K, Sun H, Cai D, Ni L,
Sun R, Chang S, Song T and Huang C: MECP2 promotes the growth of
gastric cancer cells by suppressing miR-338-mediated
antiproliferative effect. Oncotarget. 7:34845–34859. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nordstrom L, Andersson E, Kuci V,
Gustavsson E, Holm K, Ringnér M, Guldberg P and Ek S: DNA
methylation and histone modifications regulate SOX11 expression in
lymphoid and solid cancer cells. BMC Cancer. 15:2732015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tian Y, Wei W, Li L and Yang R:
Down-Regulation of miR-148a Promotes Metastasis by DNA Methylation
and is associated with prognosis of skin cancer by targeting TGIF2.
Med Sci Monit. 21:3798–3805. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu K, Zhang Y, Zhang C, Zhang Q, Li J,
Xiao F, Li Y, Zhang R, Dou D, Liang J, et al: Methylation of S100A8
is a promising diagnosis and prognostic marker in hepatocellular
carcinoma. Oncotarget. 7:56798–56810. 2016.PubMed/NCBI
|
|
19
|
Pimson C, Ekalaksananan T, Pientong C,
Promthet S, Putthanachote N, Suwanrungruang K and Wiangnon S:
Aberrant methylation of PCDH10 and RASSF1A genes in blood samples
for non-invasive diagnosis and prognostic assessment of gastric
cancer. PeerJ. 4:e21122016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xing TJ, Xu HT, Yu WQ and Jiang DF:
Methylation regulation of liver-specific microRNA-122 expression
and its effects on the proliferation and apoptosis of
hepatocellular carcinoma cells. Genet Mol Res. 12:3588–3597. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lei H, Zou D, Li Z, Luo M, Dong L, Wang B,
Yin H, Ma Y, Liu C, Wang F, et al: MicroRNA-219-2-3p functions as a
tumor suppressor in gastric cancer and is regulated by DNA
methylation. PLoS One. 8:e603692013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Noguchi S, Mori T, Nakagawa T, Itamoto K,
Haraguchi T and Mizuno T: DNA methylation contributes toward
silencing of antioncogenic microRNA-203 in human and canine
melanoma cells. Melanoma Res. 25:390–398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng H, Yang S, Yang Y, Yuan SX, Wu FQ,
Wang LL, Yan HL, Sun SH and Zhou WP: Epigenetically silenced long
noncoding-SRHC promotes proliferation of hepatocellular carcinoma.
J Cancer Res Clin Oncol. 141:1195–1203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun M, Xia R, Jin F, Xu T, Liu Z, De W and
Liu X: Downregulated long noncoding RNA MEG3 is associated with
poor prognosis and promotes cell proliferation in gastric cancer.
Tumour Biol. 35:1065–1073. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao J, Cao R and Mu H: Long non-coding RNA
UCA1 may be a novel diagnostic and predictive biomarker in plasma
for early gastric cancer. Int J Clin Exp Pathol. 8:12936–12942.
2015.PubMed/NCBI
|
|
26
|
Tong YS, Wang XW, Zhou XL, Liu ZH, Yang
TX, Shi WH, Xie HW, Lv J, Wu QQ and Cao XF: Identification of the
long non-coding RNA POU3F3 in plasma as a novel biomarker for
diagnosis of esophageal squamous cell carcinoma. Mol Cancer.
14:32015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang JP, Yang XJ, Xiao L and Wang Y: Long
noncoding RNA PVT1 as a novel serum biomarker for detection of
cervical cancer. Eur Rev Med Pharmacol Sci. 20:3980–3986.
2016.PubMed/NCBI
|
|
28
|
Peng W and Jiang A: Long noncoding RNA
CCDC26 as a potential predictor biomarker contributes to
tumorigenesis in pancreatic cancer. Biomed Pharmacother.
83:712–717. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gibb EA, Vucic EA, Enfield KS, Stewart GL,
Lonergan KM, Kennett JY, Becker-Santos DD, MacAulay CE, Lam S,
Brown CJ and Lam WL: Human cancer long non-coding RNA
transcriptomes. PLoS One. 6:e259152011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lyu JW, Yuan B, Cheng TL, Qiu ZL and Zhou
WH: Reciprocal regulation of autism-related genes MeCP2 and PTEN
via microRNAs. Sci Rep. 6:203922016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao LY, Zhang J, Guo B, Yang J, Han J,
Zhao XG, Wang XF, Liu LY, Li ZF, Song TS and Huang C: MECP2
promotes cell proliferation by activating ERK1/2 and inhibiting p38
activity in human hepatocellular carcinoma HEPG2 cells. Cell Mol
Biol (Noisy-le-grand) Suppl. 59:OL1876–OL1881. 2013.
|
|
32
|
Xu M, Bian S, Li J, He J, Chen H, Ge L,
Jiao Z, Zhang Y, Peng W, Du F, et al: MeCP2 suppresses LIN28A
expression via binding to its methylated-CpG islands in pancreatic
cancer cells. Oncotarget. 7:14476–14485. 2016.PubMed/NCBI
|
